speb/financial-data huggingface dataset:
NTES cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 18072000.00
NTES cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 75342000.00
NTES balance_sheet (quarterly, 2025-09-30) — Net PPE: 8517182000.00
NTES cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -282384000.00
NTES cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 536886000.00
NTES balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 152177453000.00
NTES balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 2612046000.00
NTES balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 2212733000.00
NTES balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 2612046000.00
NTES balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2212733000.00
NTES income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 7625748000.00
NTES income_statement (quarterly, 2025-09-30) — Normalized Income: 7757908730.00
NTES cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 12947954000.00
NTES cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 1720156000.00
NTES income_statement (quarterly, 2025-09-30) — Operating Income: 8013466000.00
NTES income_statement (quarterly, 2025-09-30) — Operating Revenue: 28358625000.00
NTES balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 3192111251.00
NTES balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 6863085000.00
NTES income_statement (quarterly, 2025-09-30) — Other Gand A: 1164573000.00
NTES income_statement (quarterly, 2025-09-30) — Other Income Expense: 1158788000.00
NTES balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 4078719000.00
NTES balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 25226119000.00
NTES balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1255583000.00
NTES income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 153198000.00
NTES balance_sheet (quarterly, 2025-09-30) — Other Payable: 3004519000.00
NTES balance_sheet (quarterly, 2025-09-30) — Other Properties: 8517182000.00
NTES balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 117766280000.00
NTES balance_sheet (quarterly, 2025-09-30) — Payables: 8035597000.00
NTES balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 23265003000.00
NTES income_statement (quarterly, 2025-09-30) — Pretax Income: 10108960000.00
NTES cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 180085000.00
NTES cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -190983000.00
NTES cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -57803514000.00
NTES cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -283645000.00
NTES balance_sheet (quarterly, 2025-09-30) — Receivables: 5962060000.00
NTES income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 10181020000.00
NTES income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 617872000.00
NTES cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -5879605000.00
NTES income_statement (quarterly, 2025-09-30) — Research And Development: 4541891000.00
NTES balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 8654295000.00
NTES cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 33580926000.00
NTES cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 1261000.00
NTES income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 4457675000.00
NTES income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5622248000.00
NTES balance_sheet (quarterly, 2025-09-30) — Share Issued: 3192111251.00
NTES cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 902201000.00
NTES balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 156256172000.00
NTES balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 152177453000.00
NTES income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 147821730.00
NTES income_statement (quarterly, 2025-09-30) — Tax Provision: 1316356000.00
NTES income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
NTES balance_sheet (quarterly, 2025-09-30) — Total Assets: 214488863000.00
NTES balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 156256172000.00
NTES balance_sheet (quarterly, 2025-09-30) — Total Debt: 7349967000.00
NTES balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 160931982000.00
NTES income_statement (quarterly, 2025-09-30) — Total Expenses: 20345159000.00
NTES balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 53556881000.00
NTES balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 43279066000.00
NTES balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3468316000.00
NTES income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 8013466000.00
NTES balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 4312685000.00
NTES income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1005590000.00
NTES income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1005590000.00
NTES cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -2244162000.00
NTES balance_sheet (quarterly, 2025-09-30) — Working Capital: 121121232000.00
NTES income_statement (annual, 2025-12-31) — +Operating Expense: 36567001000.00
NTES income_statement (quarterly, 2025-12-31) — +Operating Expense: 9373217000.00
NTES income_statement (annual, 2025-12-31) — +Total Revenue: 112625807000.00
NTES income_statement (quarterly, 2025-12-31) — +Total Revenue: 27546973000.00
NTES balance_sheet (annual, 2025-12-31) — Accounts Payable: 643164000.00
NTES balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 643164000.00
NTES balance_sheet (annual, 2025-12-31) — Accounts Receivable: 5337819000.00
NTES balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 5337819000.00
NTES balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 1265581000.00
NTES balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 1265581000.00
NTES balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7713665000.00
NTES balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7713665000.00
NTES balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 9837460000.00
NTES balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 9837460000.00
NTES cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 2724476000.00
NTES cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 857796000.00
NTES balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 16745170000.00
NTES balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 16745170000.00
NTES income_statement (annual, 2025-12-31) — Basic Average Shares: 637290800.00
NTES income_statement (quarterly, 2025-12-31) — Basic Average Shares: 638361000.00
NTES income_statement (annual, 2025-12-31) — Basic EPS: 52.95
NTES income_statement (quarterly, 2025-12-31) — Basic EPS: 9.80
NTES cash_flow (annual, 2025-12-31) — Beginning Cash Position: 54474923000.00
NTES cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 39984947000.00
NTES balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 8228886000.00
NTES balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 8228886000.00
NTES cash_flow (annual, 2025-12-31) — Capital Expenditure: -2052465000.00
NTES cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -321804000.00
NTES balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 345325000.00
NTES balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 345325000.00
NTES balance_sheet (annual, 2025-12-31) — Capital Stock: 2631000.00
NTES balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2631000.00
NTES balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 47167904000.00
NTES balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 47167904000.00
NTES balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 162610785000.00
NTES balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 162610785000.00
NTES cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -13825681000.00
NTES cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -2575287000.00
NTES cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -20159784000.00
NTES cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -3528571000.00
NTES cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -33181344000.00
NTES cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 387329000.00
NTES cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 50739800000.00
NTES cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 14823331000.00
NTES cash_flow (annual, 2025-12-31) — Change In Account Payable: -71615000.00
NTES cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -59225000.00
NTES cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 1869491000.00
NTES cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 749075000.00
NTES cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 1112836000.00
NTES cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: -436268000.00
NTES cash_flow (annual, 2025-12-31) — Change In Inventory: -117634000.00
NTES cash_flow (quarterly, 2025-12-31) — Change In Inventory: -51881000.00
NTES cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 5435054000.00
NTES cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 2778962000.00
NTES cash_flow (annual, 2025-12-31) — Change In Payable: 1169794000.00
NTES cash_flow (quarterly, 2025-12-31) — Change In Payable: -366920000.00
NTES cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 3039285000.00
NTES cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 382155000.00
NTES cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 100708000.00
NTES cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 701921000.00
NTES cash_flow (annual, 2025-12-31) — Change In Receivables: 264073000.00
NTES cash_flow (quarterly, 2025-12-31) — Change In Receivables: 594561000.00
NTES cash_flow (annual, 2025-12-31) — Change In Tax Payable: 1112836000.00
NTES cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: -436268000.00
NTES cash_flow (annual, 2025-12-31) — Change In Working Capital: 8721486000.00
NTES cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 4405718000.00
NTES cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 264073000.00
NTES cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 594561000.00
NTES cash_flow (annual, 2025-12-31) — Changes In Cash: -2601328000.00
NTES cash_flow (quarterly, 2025-12-31) — Changes In Cash: 11682089000.00
NTES balance_sheet (annual, 2025-12-31) — Common Stock: 2631000.00
NTES balance_sheet (quarterly, 2025-12-31) — Common Stock: 2631000.00
NTES cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -13825681000.00
NTES cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -2575287000.00
NTES balance_sheet (annual, 2025-12-31) — Common Stock Equity: 160296119000.00
NTES balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 160296119000.00
NTES cash_flow (annual, 2025-12-31) — Common Stock Payments: -639335000.00
NTES cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -15398000.00
NTES balance_sheet (annual, 2025-12-31) — Construction In Progress: 985107000.00
NTES balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 985107000.00
NTES income_statement (annual, 2025-12-31) — Cost Of Revenue: 40223939000.00
NTES income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 9854598000.00
NTES balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 9313911000.00
NTES balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 9313911000.00
NTES balance_sheet (annual, 2025-12-31) — Current Assets: 180615477000.00
NTES balance_sheet (quarterly, 2025-12-31) — Current Assets: 180615477000.00
NTES balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 113212000.00
NTES balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 113212000.00
NTES balance_sheet (annual, 2025-12-31) — Current Debt: 6384417000.00
NTES balance_sheet (quarterly, 2025-12-31) — Current Debt: 6384417000.00
NTES balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 6497629000.00
NTES balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 6497629000.00
NTES balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 26482257000.00
NTES balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 26482257000.00
NTES balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 26482257000.00
NTES balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 26482257000.00
NTES balance_sheet (annual, 2025-12-31) — Current Liabilities: 52368956000.00
NTES balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 52368956000.00
NTES cash_flow (annual, 2025-12-31) — Deferred Income Tax: -1254125000.00
NTES cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 204920000.00
NTES cash_flow (annual, 2025-12-31) — Deferred Tax: -1254125000.00
NTES cash_flow (quarterly, 2025-12-31) — Deferred Tax: 204920000.00
NTES cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2247427000.00
NTES cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 720367000.00
NTES cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2247427000.00
NTES cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 720367000.00
NTES income_statement (annual, 2025-12-31) — Diluted Average Shares: 643634800.00
NTES income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 645581400.00
NTES income_statement (annual, 2025-12-31) — Diluted EPS: 52.40
NTES income_statement (quarterly, 2025-12-31) — Diluted EPS: 9.65
NTES income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 33759800000.00
NTES income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 6241956000.00
NTES income_statement (annual, 2025-12-31) — EBIT: 35834867000.00
NTES income_statement (quarterly, 2025-12-31) — EBIT: 8319158000.00
NTES income_statement (annual, 2025-12-31) — EBITDA: 38082294000.00
NTES income_statement (quarterly, 2025-12-31) — EBITDA: 9039525000.00
NTES cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 1537721000.00
NTES cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 153645000.00
NTES cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -382454000.00
NTES cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -175895000.00
NTES cash_flow (annual, 2025-12-31) — End Cash Position: 51491141000.00
NTES cash_flow (quarterly, 2025-12-31) — End Cash Position: 51491141000.00
NTES cash_flow (annual, 2025-12-31) — Financing Cash Flow: -20159784000.00
NTES cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -3528571000.00
NTES cash_flow (annual, 2025-12-31) — Free Cash Flow: 48687335000.00
NTES cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 14501527000.00
NTES cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -440913000.00
NTES cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -273438000.00
NTES cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -30286000.00
NTES cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -20063000.00
NTES income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -44426000.00
NTES income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -2187051000.00
NTES balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2219601000.00
NTES balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2219601000.00
NTES income_statement (annual, 2025-12-31) — General And Administrative Expense: 4228189000.00
NTES income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1050701000.00
NTES balance_sheet (annual, 2025-12-31) — Goodwill: 1855320000.00
NTES balance_sheet (quarterly, 2025-12-31) — Goodwill: 1855320000.00
NTES balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 6850280000.00
NTES balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 6850280000.00
NTES balance_sheet (annual, 2025-12-31) — Gross PPE: 16459290000.00
NTES balance_sheet (quarterly, 2025-12-31) — Gross PPE: 16459290000.00
NTES income_statement (annual, 2025-12-31) — Gross Profit: 72401868000.00
NTES income_statement (quarterly, 2025-12-31) — Gross Profit: 17692375000.00
NTES cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 6427207000.00
NTES cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1068868000.00
NTES balance_sheet (annual, 2025-12-31) — Income Tax Payable: 2790853000.00
NTES balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 2790853000.00
NTES income_statement (annual, 2025-12-31) — Interest Income: 3953486000.00
NTES income_statement (quarterly, 2025-12-31) — Interest Income: 1002404000.00
NTES income_statement (annual, 2025-12-31) — Interest Income Non Operating: 3953486000.00
NTES income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1002404000.00
NTES cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 387982000.00
NTES cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 18313000.00
NTES balance_sheet (annual, 2025-12-31) — Inventory: 689183000.00
NTES balance_sheet (quarterly, 2025-12-31) — Inventory: 689183000.00
NTES balance_sheet (annual, 2025-12-31) — Invested Capital: 166680536000.00
NTES balance_sheet (quarterly, 2025-12-31) — Invested Capital: 166680536000.00
NTES cash_flow (annual, 2025-12-31) — Investing Cash Flow: -33181344000.00
NTES cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 387329000.00
NTES balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 16745170000.00
NTES balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 16745170000.00
NTES balance_sheet (annual, 2025-12-31) — Investments And Advances: 21457883000.00
NTES balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 21457883000.00
NTES cash_flow (annual, 2025-12-31) — Issuance Of Debt: 5552800000.00
NTES cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 92700000.00
NTES balance_sheet (annual, 2025-12-31) — Leases: 144467000.00
NTES balance_sheet (quarterly, 2025-12-31) — Leases: 144467000.00
NTES balance_sheet (annual, 2025-12-31) — Line Of Credit: 6384417000.00
NTES balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 6384417000.00
NTES balance_sheet (annual, 2025-12-31) — Loans Receivable: 79259000.00
NTES balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 79259000.00
NTES balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 232113000.00
NTES balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 232113000.00
NTES balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 232113000.00
NTES balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 232113000.00
NTES cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 5552800000.00
NTES cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 92700000.00
NTES cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -11595012000.00
NTES cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -975000000.00
NTES balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 4516632000.00
NTES balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 4516632000.00
NTES balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 7100830000.00
NTES balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 7100830000.00
NTES balance_sheet (annual, 2025-12-31) — Minority Interest: 4807890000.00
NTES balance_sheet (quarterly, 2025-12-31) — Minority Interest: 4807890000.00
NTES income_statement (annual, 2025-12-31) — Minority Interests: -1037984000.00
NTES income_statement (quarterly, 2025-12-31) — Minority Interests: -127988000.00
NTES cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 2772622000.00
NTES cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -639335000.00
NTES cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -15398000.00
NTES cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 688913000.00
NTES cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 514469000.00
NTES income_statement (annual, 2025-12-31) — Net Income: 33759800000.00
NTES income_statement (quarterly, 2025-12-31) — Net Income: 6241956000.00
NTES income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 33759800000.00
NTES income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 6241956000.00
NTES income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 34797784000.00
NTES income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 6369944000.00
NTES income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 33759800000.00
NTES income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 6241956000.00
NTES income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 33759800000.00
NTES income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 6241956000.00
NTES cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 34797784000.00
NTES cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 6369944000.00
NTES income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 34797784000.00
NTES income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 6369944000.00
NTES cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -987089000.00
NTES cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -183986000.00
NTES income_statement (annual, 2025-12-31) — Net Interest Income: 3953486000.00
NTES income_statement (quarterly, 2025-12-31) — Net Interest Income: 1002404000.00
NTES cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -27112686000.00
NTES cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 4796719000.00
NTES cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -5798576000.00
NTES cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -938705000.00
NTES cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -6042212000.00
NTES cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -882300000.00
NTES income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 3953486000.00
NTES income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 1002404000.00
NTES cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 103808000.00
NTES cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 819000.00
NTES cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -6834701000.00
NTES cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -6881998000.00
NTES balance_sheet (annual, 2025-12-31) — Net PPE: 8745625000.00
NTES balance_sheet (quarterly, 2025-12-31) — Net PPE: 8745625000.00
NTES cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1019490000.00
NTES cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -116028000.00
NTES cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 243636000.00
NTES cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -56405000.00
NTES balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 153445839000.00
NTES balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 153445839000.00
NTES balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 516946000.00
NTES balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 516946000.00
NTES balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 2831423000.00
NTES balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 2831423000.00
NTES balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 2637258000.00
NTES balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 2637258000.00
NTES balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 2831423000.00
NTES balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 2831423000.00
NTES balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2637258000.00
NTES balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2637258000.00
NTES balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 16057000.00
NTES balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 16057000.00
NTES balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 135183000.00
NTES balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 135183000.00
NTES income_statement (annual, 2025-12-31) — Normalized EBITDA: 38126720000.00
NTES income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 11226576000.00
NTES income_statement (annual, 2025-12-31) — Normalized Income: 33797662075.85
NTES income_statement (quarterly, 2025-12-31) — Normalized Income: 8070132989.10
NTES cash_flow (annual, 2025-12-31) — Operating Cash Flow: 50739800000.00
NTES cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 14823331000.00
NTES cash_flow (annual, 2025-12-31) — Operating Gains Losses: 1755435000.00
NTES cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 374613000.00
NTES income_statement (annual, 2025-12-31) — Operating Income: 35834867000.00
NTES income_statement (quarterly, 2025-12-31) — Operating Income: 8319158000.00
NTES income_statement (annual, 2025-12-31) — Operating Revenue: 112625807000.00
NTES income_statement (quarterly, 2025-12-31) — Operating Revenue: 27546973000.00
NTES balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 3192111251.00
NTES balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 3192111251.00
NTES balance_sheet (annual, 2025-12-31) — Other Current Assets: 198065000.00
NTES balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 198065000.00
NTES balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 2219601000.00
NTES balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 2219601000.00
NTES income_statement (annual, 2025-12-31) — Other Gand A: 4228189000.00
NTES income_statement (quarterly, 2025-12-31) — Other Gand A: 1050701000.00
NTES income_statement (annual, 2025-12-31) — Other Income Expense: 1042117000.00
NTES income_statement (quarterly, 2025-12-31) — Other Income Expense: -1701188000.00
NTES balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 4994960000.00
NTES balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 4994960000.00
NTES balance_sheet (annual, 2025-12-31) — Other Investments: 196081000.00
NTES balance_sheet (quarterly, 2025-12-31) — Other Investments: 196081000.00
NTES balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 246186000.00
NTES balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 246186000.00
NTES balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1072724000.00
NTES balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1072724000.00
NTES income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1086543000.00
NTES income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 485863000.00
NTES balance_sheet (annual, 2025-12-31) — Other Payable: 5557852000.00
NTES balance_sheet (quarterly, 2025-12-31) — Other Payable: 5557852000.00
NTES balance_sheet (annual, 2025-12-31) — Other Receivables: 508468000.00
NTES balance_sheet (quarterly, 2025-12-31) — Other Receivables: 508468000.00
NTES balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 115442881000.00
NTES balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 115442881000.00
NTES balance_sheet (annual, 2025-12-31) — Payables: 10075159000.00
NTES balance_sheet (quarterly, 2025-12-31) — Payables: 10075159000.00
NTES balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 19389070000.00
NTES balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 19389070000.00
NTES balance_sheet (annual, 2025-12-31) — Prepaid Assets: 5606973000.00
NTES balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 5606973000.00
NTES income_statement (annual, 2025-12-31) — Pretax Income: 40830470000.00
NTES income_statement (quarterly, 2025-12-31) — Pretax Income: 7620374000.00
NTES balance_sheet (annual, 2025-12-31) — Properties: 0.00
NTES balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
NTES cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 367513000.00
NTES cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 17478000.00
NTES cash_flow (annual, 2025-12-31) — Purchase Of Business: -268860000.00
NTES cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -987089000.00
NTES cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -183986000.00
NTES cash_flow (annual, 2025-12-31) — Purchase Of Investment: -192613831000.00
NTES cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -40263170000.00
NTES cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1065376000.00
NTES cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -137818000.00
NTES balance_sheet (annual, 2025-12-31) — Receivables: 7191127000.00
NTES balance_sheet (quarterly, 2025-12-31) — Receivables: 7191127000.00
NTES income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 40223939000.00
NTES income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 9854598000.00
NTES income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2247427000.00
NTES income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 720367000.00
NTES cash_flow (annual, 2025-12-31) — Repayment Of Debt: -11595012000.00
NTES cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -975000000.00
NTES cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -639335000.00
NTES cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -15398000.00
NTES income_statement (annual, 2025-12-31) — Research And Development: 17719110000.00
NTES income_statement (quarterly, 2025-12-31) — Research And Development: 4434260000.00
NTES balance_sheet (annual, 2025-12-31) — Restricted Cash: 4319344000.00
NTES balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 4319344000.00
NTES balance_sheet (annual, 2025-12-31) — Retained Earnings: 149755000000.00
NTES balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 149755000000.00
NTES cash_flow (annual, 2025-12-31) — Sale Of Business: 3041482000.00
NTES cash_flow (annual, 2025-12-31) — Sale Of Investment: 165501145000.00
NTES cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 45059889000.00
NTES cash_flow (annual, 2025-12-31) — Sale Of PPE: 45886000.00
NTES cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 21790000.00
NTES income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 14619702000.00
NTES income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 3888256000.00
NTES income_statement (annual, 2025-12-31) — Selling General And Administration: 18847891000.00
NTES income_statement (quarterly, 2025-12-31) — Selling General And Administration: 4938957000.00
NTES balance_sheet (annual, 2025-12-31) — Share Issued: 3219564581.00
NTES balance_sheet (quarterly, 2025-12-31) — Share Issued: 3219564581.00
NTES cash_flow (annual, 2025-12-31) — Stock Based Compensation: 3647662000.00
NTES cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 847194000.00
NTES balance_sheet (annual, 2025-12-31) — Stockholders Equity: 160296119000.00
NTES balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 160296119000.00
NTES balance_sheet (annual, 2025-12-31) — Tangible Book Value: 153445839000.00
NTES balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 153445839000.00
NTES income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -6563924.15
NTES income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -358874010.90
NTES income_statement (annual, 2025-12-31) — Tax Provision: 6032686000.00
NTES income_statement (quarterly, 2025-12-31) — Tax Provision: 1250430000.00
NTES income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
NTES income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.16
NTES balance_sheet (annual, 2025-12-31) — Total Assets: 221415060000.00
NTES balance_sheet (quarterly, 2025-12-31) — Total Assets: 221415060000.00
NTES balance_sheet (annual, 2025-12-31) — Total Capitalization: 160296119000.00
NTES balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 160296119000.00
NTES balance_sheet (annual, 2025-12-31) — Total Debt: 6729742000.00
NTES balance_sheet (quarterly, 2025-12-31) — Total Debt: 6729742000.00
NTES balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 165104009000.00
NTES balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 165104009000.00
NTES income_statement (annual, 2025-12-31) — Total Expenses: 76790940000.00
NTES income_statement (quarterly, 2025-12-31) — Total Expenses: 19227815000.00
NTES balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 56311051000.00
NTES balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 56311051000.00
NTES balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 40799583000.00
NTES balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 40799583000.00
NTES balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3942095000.00
NTES balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3942095000.00
NTES income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 35834867000.00
NTES income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 8319158000.00
NTES balance_sheet (annual, 2025-12-31) — Total Tax Payable: 3874143000.00
NTES balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 3874143000.00
NTES income_statement (annual, 2025-12-31) — Total Unusual Items: -44426000.00
NTES income_statement (quarterly, 2025-12-31) — Total Unusual Items: -2187051000.00
NTES income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -44426000.00
NTES income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -2187051000.00
NTES balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 27453330.00
NTES balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 27453330.00
NTES balance_sheet (annual, 2025-12-31) — Treasury Stock: 1518573000.00
NTES balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 1518573000.00
NTES cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -2267858000.00
NTES cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 1025301000.00
NTES balance_sheet (annual, 2025-12-31) — Working Capital: 128246521000.00
NTES balance_sheet (quarterly, 2025-12-31) — Working Capital: 128246521000.00
NTES income_statement (quarterly, 2026-03-31) — +Operating Expense: 8560239000.00
NTES income_statement (quarterly, 2026-03-31) — +Total Revenue: 30591281000.00
NTES balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 780921000.00
NTES balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 6492901000.00
NTES cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 344871000.00
NTES balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 3045000000.00
NTES income_statement (quarterly, 2026-03-31) — Basic Average Shares: 639624600.00
NTES income_statement (quarterly, 2026-03-31) — Basic EPS: 16.70
NTES cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 51491141000.00
NTES cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -602167000.00
NTES balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 50815211000.00
NTES balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 170903837000.00
NTES cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -5156320000.00
NTES cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1797738000.00
NTES cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -7764122000.00
NTES cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 13733071000.00
NTES cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 134445000.00
NTES cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -21044000.00
NTES cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 1895324000.00
NTES cash_flow (quarterly, 2026-03-31) — Change In Inventory: 143099000.00
NTES cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 1384445000.00
NTES cash_flow (quarterly, 2026-03-31) — Change In Payable: -223790000.00
NTES cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -244834000.00
NTES cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 116152000.00
NTES cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1188837000.00
NTES cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 1895324000.00
NTES cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 210025000.00
NTES cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -1188837000.00
NTES cash_flow (quarterly, 2026-03-31) — Changes In Cash: 4171211000.00
NTES cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -5156320000.00
NTES balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 164722217000.00
NTES cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1314003000.00
NTES income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 9374209000.00
NTES balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 15480778000.00
NTES balance_sheet (quarterly, 2026-03-31) — Current Assets: 188658637000.00
NTES balance_sheet (quarterly, 2026-03-31) — Current Debt: 10955460000.00
NTES balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 10955460000.00
NTES balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 21811530000.00
NTES balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 21811530000.00
NTES balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 57437159000.00
NTES cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 532257000.00
NTES cash_flow (quarterly, 2026-03-31) — Deferred Tax: 532257000.00
NTES cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 430583000.00
NTES cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 430583000.00
NTES income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 645465000.00
NTES income_statement (quarterly, 2026-03-31) — Diluted EPS: 16.55
NTES income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 10674106000.00
NTES income_statement (quarterly, 2026-03-31) — EBIT: 12656833000.00
NTES income_statement (quarterly, 2026-03-31) — EBITDA: 13087416000.00
NTES cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 442575000.00
NTES cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -340829000.00
NTES cash_flow (quarterly, 2026-03-31) — End Cash Position: 55321523000.00
NTES cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1797738000.00
NTES cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 13130904000.00
NTES cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -1071442000.00
NTES cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -565000.00
NTES income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -616636000.00
NTES income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 636597000.00
NTES balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 4014831000.00
NTES balance_sheet (quarterly, 2026-03-31) — Gross PPE: 8311363000.00
NTES income_statement (quarterly, 2026-03-31) — Gross Profit: 21217072000.00
NTES cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 1464650000.00
NTES income_statement (quarterly, 2026-03-31) — Interest Income: 890267000.00
NTES income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 890267000.00
NTES cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 78326000.00
NTES balance_sheet (quarterly, 2026-03-31) — Inventory: 546030000.00
NTES balance_sheet (quarterly, 2026-03-31) — Invested Capital: 175677677000.00
NTES cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -7764122000.00
NTES balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 3045000000.00
NTES balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 3045000000.00
NTES cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 6134520000.00
NTES balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 10955460000.00
NTES cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 6134520000.00
NTES cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -2620900000.00
NTES balance_sheet (quarterly, 2026-03-31) — Minority Interest: 4627246000.00
NTES income_statement (quarterly, 2026-03-31) — Minority Interests: -171498000.00
NTES cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -1314003000.00
NTES cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 643942000.00
NTES income_statement (quarterly, 2026-03-31) — Net Income: 10674106000.00
NTES income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 10674106000.00
NTES income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 10845604000.00
NTES income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 10674106000.00
NTES income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 10674106000.00
NTES cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 10845604000.00
NTES income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 10845604000.00
NTES cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -290019000.00
NTES income_statement (quarterly, 2026-03-31) — Net Interest Income: 890267000.00
NTES cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -7229537000.00
NTES cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 4696003000.00
NTES cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 3513620000.00
NTES income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 890267000.00
NTES cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -23418000.00
NTES cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 65909000.00
NTES balance_sheet (quarterly, 2026-03-31) — Net PPE: 8311363000.00
NTES cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -310475000.00
NTES cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 1182383000.00
NTES balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 160707386000.00
NTES balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 2894530000.00
NTES balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 3232494000.00
NTES balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 2894530000.00
NTES balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 3232494000.00
NTES income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 13704052000.00
NTES income_statement (quarterly, 2026-03-31) — Normalized Income: 11174197796.00
NTES cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 13733071000.00
NTES cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 14510000.00
NTES income_statement (quarterly, 2026-03-31) — Operating Income: 12656833000.00
NTES income_statement (quarterly, 2026-03-31) — Operating Revenue: 30591281000.00
NTES balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 3203577346.00
NTES balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 6212901000.00
NTES income_statement (quarterly, 2026-03-31) — Other Gand A: 636597000.00
NTES income_statement (quarterly, 2026-03-31) — Other Income Expense: -177658000.00
NTES balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 4014831000.00
NTES balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 24472684000.00
NTES balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1377929000.00
NTES income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 438978000.00
NTES balance_sheet (quarterly, 2026-03-31) — Other Payable: 2642579000.00
NTES balance_sheet (quarterly, 2026-03-31) — Other Properties: 8311363000.00
NTES balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 120088626000.00
NTES balance_sheet (quarterly, 2026-03-31) — Payables: 9189391000.00
NTES balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 24670169000.00
NTES income_statement (quarterly, 2026-03-31) — Pretax Income: 13369442000.00
NTES cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 6719000.00
NTES cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -290019000.00
NTES cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -55463836000.00
NTES cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -312148000.00
NTES balance_sheet (quarterly, 2026-03-31) — Receivables: 6492901000.00
NTES income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 9374209000.00
NTES income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 430583000.00
NTES cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -2620900000.00
NTES cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1314003000.00
NTES income_statement (quarterly, 2026-03-31) — Research And Development: 4482157000.00
NTES balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 4502968000.00
NTES cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 48234299000.00
NTES cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 1673000.00
NTES income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 3441485000.00
NTES income_statement (quarterly, 2026-03-31) — Selling General And Administration: 4078082000.00
NTES balance_sheet (quarterly, 2026-03-31) — Share Issued: 3203577346.00
NTES cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 616180000.00
NTES balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 164722217000.00
NTES balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 160707386000.00
NTES income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -116544204.00
NTES income_statement (quarterly, 2026-03-31) — Tax Provision: 2523838000.00
NTES income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.19
NTES balance_sheet (quarterly, 2026-03-31) — Total Assets: 231397045000.00
NTES balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 164722217000.00
NTES balance_sheet (quarterly, 2026-03-31) — Total Debt: 10955460000.00
NTES balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 169349463000.00
NTES income_statement (quarterly, 2026-03-31) — Total Expenses: 17934448000.00
NTES balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 62047582000.00
NTES balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 42738408000.00
NTES balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 4610423000.00
NTES income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 12656833000.00